Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$246,968,654
+$90,178,222 QoQ
Shares Held
205,905
+20.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
#236
of 4,605 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Zurich Insurance Group Ltd/FI holds $782,126,991 across 9 Drug Manufacturers - General names. LLY ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
205,905 | $246,968,654 | |
| 2 | JNJ |
Johnson & Johnson
|
544,175 | $138,204,124 | |
| 3 | AZN |
Astrazeneca PLC
|
621,907 | $117,926,005 | |
| 4 | ABBV |
AbbVie Inc.
|
323,672 | $81,448,822 | |
| 5 | MRK |
Merck & Co., Inc.
|
631,197 | $81,108,814 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
354,330 | $44,766,052 | |
| 7 | AMGN |
Amgen Inc
|
113,643 | $41,152,403 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
398,360 | $22,953,503 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,968,654 | 205,905 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $156,790,432 | 170,467 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $252,693,830 | 235,134 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $133,187,754 | 174,558 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $159,404,530 | 204,488 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $186,269,960 | 225,533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $158,801,172 | 205,701 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $188,025,704 | 212,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $267,806,877 | 295,795 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $182,741,248 | 234,898 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $133,593,022 | 229,179 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $141,397,861 | 263,247 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $184,527,215 | 393,465 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $85,232,722 | 248,188 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,103,126 | 101,419 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $66,912,432 | 206,935 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $94,891,097 | 292,666 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $116,127,616 | 405,516 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||